nodes	percent_of_prediction	percent_of_DWPC	metapath
Cromoglicic acid—S100P—renal system—urinary bladder cancer	0.0868	0.324	CbGeAlD
Cromoglicic acid—S100P—female reproductive system—urinary bladder cancer	0.0695	0.259	CbGeAlD
Cromoglicic acid—KCNMA1—prostate gland—urinary bladder cancer	0.028	0.105	CbGeAlD
Cromoglicic acid—KCNMA1—epithelium—urinary bladder cancer	0.0206	0.0768	CbGeAlD
Cromoglicic acid—KCNMA1—smooth muscle tissue—urinary bladder cancer	0.0198	0.074	CbGeAlD
Cromoglicic acid—KCNMA1—renal system—urinary bladder cancer	0.0191	0.0712	CbGeAlD
Cromoglicic acid—KCNMA1—female reproductive system—urinary bladder cancer	0.0153	0.0571	CbGeAlD
Cromoglicic acid—KCNMA1—lymph node—urinary bladder cancer	0.00895	0.0334	CbGeAlD
Cromoglicic acid—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00123	0.00168	CcSEcCtD
Cromoglicic acid—Oedema—Cisplatin—urinary bladder cancer	0.00123	0.00168	CcSEcCtD
Cromoglicic acid—Mood swings—Epirubicin—urinary bladder cancer	0.00122	0.00167	CcSEcCtD
Cromoglicic acid—Lethargy—Doxorubicin—urinary bladder cancer	0.00121	0.00166	CcSEcCtD
Cromoglicic acid—Hypotension—Fluorouracil—urinary bladder cancer	0.00121	0.00166	CcSEcCtD
Cromoglicic acid—Cough—Etoposide—urinary bladder cancer	0.00121	0.00165	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.0012	0.00164	CcSEcCtD
Cromoglicic acid—Tachycardia—Cisplatin—urinary bladder cancer	0.0012	0.00164	CcSEcCtD
Cromoglicic acid—Convulsion—Etoposide—urinary bladder cancer	0.0012	0.00164	CcSEcCtD
Cromoglicic acid—Insomnia—Gemcitabine—urinary bladder cancer	0.00119	0.00163	CcSEcCtD
Cromoglicic acid—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00119	0.00162	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00118	0.00162	CcSEcCtD
Cromoglicic acid—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00118	0.00161	CcSEcCtD
Cromoglicic acid—Chest pain—Etoposide—urinary bladder cancer	0.00118	0.00161	CcSEcCtD
Cromoglicic acid—Eosinophilia—Methotrexate—urinary bladder cancer	0.00118	0.00161	CcSEcCtD
Cromoglicic acid—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00118	0.00161	CcSEcCtD
Cromoglicic acid—Insomnia—Fluorouracil—urinary bladder cancer	0.00117	0.00161	CcSEcCtD
Cromoglicic acid—Somnolence—Gemcitabine—urinary bladder cancer	0.00117	0.0016	CcSEcCtD
Cromoglicic acid—Migraine—Doxorubicin—urinary bladder cancer	0.00117	0.0016	CcSEcCtD
Cromoglicic acid—Affect lability—Doxorubicin—urinary bladder cancer	0.00117	0.0016	CcSEcCtD
Cromoglicic acid—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00117	0.00159	CcSEcCtD
Cromoglicic acid—Discomfort—Etoposide—urinary bladder cancer	0.00116	0.00159	CcSEcCtD
Cromoglicic acid—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00116	0.00158	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00116	0.00158	CcSEcCtD
Cromoglicic acid—Somnolence—Fluorouracil—urinary bladder cancer	0.00115	0.00158	CcSEcCtD
Cromoglicic acid—Hypotension—Cisplatin—urinary bladder cancer	0.00115	0.00157	CcSEcCtD
Cromoglicic acid—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00114	0.00156	CcSEcCtD
Cromoglicic acid—Fatigue—Gemcitabine—urinary bladder cancer	0.00114	0.00156	CcSEcCtD
Cromoglicic acid—Constipation—Gemcitabine—urinary bladder cancer	0.00113	0.00154	CcSEcCtD
Cromoglicic acid—Pain—Gemcitabine—urinary bladder cancer	0.00113	0.00154	CcSEcCtD
Cromoglicic acid—Pancytopenia—Methotrexate—urinary bladder cancer	0.00113	0.00154	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00113	0.00154	CcSEcCtD
Cromoglicic acid—Mood swings—Doxorubicin—urinary bladder cancer	0.00113	0.00154	CcSEcCtD
Cromoglicic acid—Asthenia—Thiotepa—urinary bladder cancer	0.00113	0.00154	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00112	0.00153	CcSEcCtD
Cromoglicic acid—Dysphagia—Epirubicin—urinary bladder cancer	0.00111	0.00152	CcSEcCtD
Cromoglicic acid—Neutropenia—Methotrexate—urinary bladder cancer	0.00111	0.00152	CcSEcCtD
Cromoglicic acid—Dysuria—Methotrexate—urinary bladder cancer	0.00111	0.00152	CcSEcCtD
Cromoglicic acid—Pain—Fluorouracil—urinary bladder cancer	0.00111	0.00152	CcSEcCtD
Cromoglicic acid—Paraesthesia—Cisplatin—urinary bladder cancer	0.00111	0.00151	CcSEcCtD
Cromoglicic acid—Tachycardia—Etoposide—urinary bladder cancer	0.0011	0.0015	CcSEcCtD
Cromoglicic acid—Eosinophilia—Epirubicin—urinary bladder cancer	0.0011	0.0015	CcSEcCtD
Cromoglicic acid—Dyspnoea—Cisplatin—urinary bladder cancer	0.0011	0.0015	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00109	0.00149	CcSEcCtD
Cromoglicic acid—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00109	0.00149	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00108	0.00148	CcSEcCtD
Cromoglicic acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.00107	0.00147	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00107	0.00146	CcSEcCtD
Cromoglicic acid—Drowsiness—Methotrexate—urinary bladder cancer	0.00106	0.00145	CcSEcCtD
Cromoglicic acid—Pancytopenia—Epirubicin—urinary bladder cancer	0.00106	0.00144	CcSEcCtD
Cromoglicic acid—Hypotension—Etoposide—urinary bladder cancer	0.00105	0.00144	CcSEcCtD
Cromoglicic acid—Pain—Cisplatin—urinary bladder cancer	0.00105	0.00144	CcSEcCtD
Cromoglicic acid—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00104	0.00143	CcSEcCtD
Cromoglicic acid—Dysuria—Epirubicin—urinary bladder cancer	0.00104	0.00142	CcSEcCtD
Cromoglicic acid—Neutropenia—Epirubicin—urinary bladder cancer	0.00104	0.00142	CcSEcCtD
Cromoglicic acid—Dizziness—Thiotepa—urinary bladder cancer	0.00104	0.00142	CcSEcCtD
Cromoglicic acid—Stomatitis—Methotrexate—urinary bladder cancer	0.00103	0.00141	CcSEcCtD
Cromoglicic acid—Urticaria—Fluorouracil—urinary bladder cancer	0.00103	0.00141	CcSEcCtD
Cromoglicic acid—Dysphagia—Doxorubicin—urinary bladder cancer	0.00103	0.00141	CcSEcCtD
Cromoglicic acid—Pollakiuria—Epirubicin—urinary bladder cancer	0.00103	0.0014	CcSEcCtD
Cromoglicic acid—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00103	0.0014	CcSEcCtD
Cromoglicic acid—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00102	0.00139	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00101	0.00139	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00101	0.00139	CcSEcCtD
Cromoglicic acid—Paraesthesia—Etoposide—urinary bladder cancer	0.00101	0.00138	CcSEcCtD
Cromoglicic acid—Dyspnoea—Etoposide—urinary bladder cancer	0.00101	0.00137	CcSEcCtD
Cromoglicic acid—Somnolence—Etoposide—urinary bladder cancer	0.001	0.00137	CcSEcCtD
Cromoglicic acid—Epistaxis—Methotrexate—urinary bladder cancer	0.000999	0.00137	CcSEcCtD
Cromoglicic acid—Drowsiness—Epirubicin—urinary bladder cancer	0.000991	0.00135	CcSEcCtD
Cromoglicic acid—Rash—Thiotepa—urinary bladder cancer	0.00099	0.00135	CcSEcCtD
Cromoglicic acid—Dermatitis—Thiotepa—urinary bladder cancer	0.000989	0.00135	CcSEcCtD
Cromoglicic acid—Headache—Thiotepa—urinary bladder cancer	0.000984	0.00134	CcSEcCtD
Cromoglicic acid—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000977	0.00134	CcSEcCtD
Cromoglicic acid—Body temperature increased—Cisplatin—urinary bladder cancer	0.000973	0.00133	CcSEcCtD
Cromoglicic acid—Fatigue—Etoposide—urinary bladder cancer	0.000973	0.00133	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000972	0.00133	CcSEcCtD
Cromoglicic acid—Stomatitis—Epirubicin—urinary bladder cancer	0.000966	0.00132	CcSEcCtD
Cromoglicic acid—Pain—Etoposide—urinary bladder cancer	0.000965	0.00132	CcSEcCtD
Cromoglicic acid—Constipation—Etoposide—urinary bladder cancer	0.000965	0.00132	CcSEcCtD
Cromoglicic acid—Dysuria—Doxorubicin—urinary bladder cancer	0.000962	0.00131	CcSEcCtD
Cromoglicic acid—Neutropenia—Doxorubicin—urinary bladder cancer	0.000962	0.00131	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000957	0.00131	CcSEcCtD
Cromoglicic acid—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00095	0.0013	CcSEcCtD
Cromoglicic acid—Asthenia—Gemcitabine—urinary bladder cancer	0.000948	0.0013	CcSEcCtD
Cromoglicic acid—Pharyngitis—Methotrexate—urinary bladder cancer	0.000944	0.00129	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000939	0.00128	CcSEcCtD
Cromoglicic acid—Epistaxis—Epirubicin—urinary bladder cancer	0.000935	0.00128	CcSEcCtD
Cromoglicic acid—Nausea—Thiotepa—urinary bladder cancer	0.000933	0.00127	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Etoposide—urinary bladder cancer	0.00093	0.00127	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000922	0.00126	CcSEcCtD
Cromoglicic acid—Drowsiness—Doxorubicin—urinary bladder cancer	0.000917	0.00125	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000907	0.00124	CcSEcCtD
Cromoglicic acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000904	0.00124	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000899	0.00123	CcSEcCtD
Cromoglicic acid—Urticaria—Etoposide—urinary bladder cancer	0.000896	0.00122	CcSEcCtD
Cromoglicic acid—Stomatitis—Doxorubicin—urinary bladder cancer	0.000894	0.00122	CcSEcCtD
Cromoglicic acid—Abdominal pain—Etoposide—urinary bladder cancer	0.000892	0.00122	CcSEcCtD
Cromoglicic acid—Body temperature increased—Etoposide—urinary bladder cancer	0.000892	0.00122	CcSEcCtD
Cromoglicic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000889	0.00121	CcSEcCtD
Cromoglicic acid—Tinnitus—Methotrexate—urinary bladder cancer	0.000887	0.00121	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000886	0.00121	CcSEcCtD
Cromoglicic acid—Asthenia—Cisplatin—urinary bladder cancer	0.000883	0.00121	CcSEcCtD
Cromoglicic acid—Pharyngitis—Epirubicin—urinary bladder cancer	0.000883	0.00121	CcSEcCtD
Cromoglicic acid—Epistaxis—Doxorubicin—urinary bladder cancer	0.000865	0.00118	CcSEcCtD
Cromoglicic acid—Dizziness—Fluorouracil—urinary bladder cancer	0.000859	0.00117	CcSEcCtD
Cromoglicic acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000842	0.00115	CcSEcCtD
Cromoglicic acid—Rash—Gemcitabine—urinary bladder cancer	0.000833	0.00114	CcSEcCtD
Cromoglicic acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.000832	0.00114	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Etoposide—urinary bladder cancer	0.000831	0.00114	CcSEcCtD
Cromoglicic acid—Tinnitus—Epirubicin—urinary bladder cancer	0.00083	0.00113	CcSEcCtD
Cromoglicic acid—Erythema—Methotrexate—urinary bladder cancer	0.000828	0.00113	CcSEcCtD
Cromoglicic acid—Headache—Gemcitabine—urinary bladder cancer	0.000828	0.00113	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000819	0.00112	CcSEcCtD
Cromoglicic acid—Rash—Fluorouracil—urinary bladder cancer	0.000819	0.00112	CcSEcCtD
Cromoglicic acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.000818	0.00112	CcSEcCtD
Cromoglicic acid—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000817	0.00112	CcSEcCtD
Cromoglicic acid—Headache—Fluorouracil—urinary bladder cancer	0.000814	0.00111	CcSEcCtD
Cromoglicic acid—Dysgeusia—Methotrexate—urinary bladder cancer	0.000811	0.00111	CcSEcCtD
Cromoglicic acid—Asthenia—Etoposide—urinary bladder cancer	0.000809	0.00111	CcSEcCtD
Cromoglicic acid—Nausea—Gemcitabine—urinary bladder cancer	0.000785	0.00107	CcSEcCtD
Cromoglicic acid—Rash—Cisplatin—urinary bladder cancer	0.000776	0.00106	CcSEcCtD
Cromoglicic acid—Dermatitis—Cisplatin—urinary bladder cancer	0.000776	0.00106	CcSEcCtD
Cromoglicic acid—Erythema—Epirubicin—urinary bladder cancer	0.000775	0.00106	CcSEcCtD
Cromoglicic acid—Diarrhoea—Etoposide—urinary bladder cancer	0.000772	0.00105	CcSEcCtD
Cromoglicic acid—Nausea—Fluorouracil—urinary bladder cancer	0.000772	0.00105	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000768	0.00105	CcSEcCtD
Cromoglicic acid—Tinnitus—Doxorubicin—urinary bladder cancer	0.000768	0.00105	CcSEcCtD
Cromoglicic acid—Anaemia—Methotrexate—urinary bladder cancer	0.000765	0.00105	CcSEcCtD
Cromoglicic acid—Flatulence—Epirubicin—urinary bladder cancer	0.000763	0.00104	CcSEcCtD
Cromoglicic acid—Tension—Epirubicin—urinary bladder cancer	0.00076	0.00104	CcSEcCtD
Cromoglicic acid—Dysgeusia—Epirubicin—urinary bladder cancer	0.000759	0.00104	CcSEcCtD
Cromoglicic acid—Nervousness—Epirubicin—urinary bladder cancer	0.000753	0.00103	CcSEcCtD
Cromoglicic acid—Malaise—Methotrexate—urinary bladder cancer	0.000747	0.00102	CcSEcCtD
Cromoglicic acid—Dizziness—Etoposide—urinary bladder cancer	0.000746	0.00102	CcSEcCtD
Cromoglicic acid—Vertigo—Methotrexate—urinary bladder cancer	0.000744	0.00102	CcSEcCtD
Cromoglicic acid—Nausea—Cisplatin—urinary bladder cancer	0.000731	0.000999	CcSEcCtD
Cromoglicic acid—Cough—Methotrexate—urinary bladder cancer	0.000722	0.000987	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000719	0.000982	CcSEcCtD
Cromoglicic acid—Convulsion—Methotrexate—urinary bladder cancer	0.000717	0.00098	CcSEcCtD
Cromoglicic acid—Erythema—Doxorubicin—urinary bladder cancer	0.000717	0.00098	CcSEcCtD
Cromoglicic acid—Anaemia—Epirubicin—urinary bladder cancer	0.000716	0.000979	CcSEcCtD
Cromoglicic acid—Rash—Etoposide—urinary bladder cancer	0.000711	0.000972	CcSEcCtD
Cromoglicic acid—Dermatitis—Etoposide—urinary bladder cancer	0.000711	0.000971	CcSEcCtD
Cromoglicic acid—Headache—Etoposide—urinary bladder cancer	0.000707	0.000966	CcSEcCtD
Cromoglicic acid—Flatulence—Doxorubicin—urinary bladder cancer	0.000706	0.000965	CcSEcCtD
Cromoglicic acid—Chest pain—Methotrexate—urinary bladder cancer	0.000705	0.000963	CcSEcCtD
Cromoglicic acid—Arthralgia—Methotrexate—urinary bladder cancer	0.000705	0.000963	CcSEcCtD
Cromoglicic acid—Myalgia—Methotrexate—urinary bladder cancer	0.000705	0.000963	CcSEcCtD
Cromoglicic acid—Tension—Doxorubicin—urinary bladder cancer	0.000703	0.000961	CcSEcCtD
Cromoglicic acid—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000702	0.000959	CcSEcCtD
Cromoglicic acid—Malaise—Epirubicin—urinary bladder cancer	0.000699	0.000955	CcSEcCtD
Cromoglicic acid—Discomfort—Methotrexate—urinary bladder cancer	0.000696	0.000952	CcSEcCtD
Cromoglicic acid—Nervousness—Doxorubicin—urinary bladder cancer	0.000696	0.000951	CcSEcCtD
Cromoglicic acid—Vertigo—Epirubicin—urinary bladder cancer	0.000696	0.000951	CcSEcCtD
Cromoglicic acid—Palpitations—Epirubicin—urinary bladder cancer	0.000685	0.000936	CcSEcCtD
Cromoglicic acid—Cough—Epirubicin—urinary bladder cancer	0.000676	0.000924	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000676	0.000923	CcSEcCtD
Cromoglicic acid—Convulsion—Epirubicin—urinary bladder cancer	0.000671	0.000917	CcSEcCtD
Cromoglicic acid—Nausea—Etoposide—urinary bladder cancer	0.00067	0.000916	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000665	0.000909	CcSEcCtD
Cromoglicic acid—Anaemia—Doxorubicin—urinary bladder cancer	0.000663	0.000905	CcSEcCtD
Cromoglicic acid—Chest pain—Epirubicin—urinary bladder cancer	0.00066	0.000901	CcSEcCtD
Cromoglicic acid—Arthralgia—Epirubicin—urinary bladder cancer	0.00066	0.000901	CcSEcCtD
Cromoglicic acid—Myalgia—Epirubicin—urinary bladder cancer	0.00066	0.000901	CcSEcCtD
Cromoglicic acid—Anxiety—Epirubicin—urinary bladder cancer	0.000657	0.000898	CcSEcCtD
Cromoglicic acid—Discomfort—Epirubicin—urinary bladder cancer	0.000652	0.000891	CcSEcCtD
Cromoglicic acid—Malaise—Doxorubicin—urinary bladder cancer	0.000646	0.000883	CcSEcCtD
Cromoglicic acid—Vertigo—Doxorubicin—urinary bladder cancer	0.000644	0.00088	CcSEcCtD
Cromoglicic acid—Palpitations—Doxorubicin—urinary bladder cancer	0.000634	0.000866	CcSEcCtD
Cromoglicic acid—Oedema—Epirubicin—urinary bladder cancer	0.000632	0.000864	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000632	0.000864	CcSEcCtD
Cromoglicic acid—Hypotension—Methotrexate—urinary bladder cancer	0.000631	0.000863	CcSEcCtD
Cromoglicic acid—Cough—Doxorubicin—urinary bladder cancer	0.000626	0.000855	CcSEcCtD
Cromoglicic acid—Convulsion—Doxorubicin—urinary bladder cancer	0.000621	0.000849	CcSEcCtD
Cromoglicic acid—Tachycardia—Epirubicin—urinary bladder cancer	0.000617	0.000843	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000616	0.000841	CcSEcCtD
Cromoglicic acid—Insomnia—Methotrexate—urinary bladder cancer	0.000611	0.000835	CcSEcCtD
Cromoglicic acid—Chest pain—Doxorubicin—urinary bladder cancer	0.00061	0.000834	CcSEcCtD
Cromoglicic acid—Arthralgia—Doxorubicin—urinary bladder cancer	0.00061	0.000834	CcSEcCtD
Cromoglicic acid—Myalgia—Doxorubicin—urinary bladder cancer	0.00061	0.000834	CcSEcCtD
Cromoglicic acid—Anxiety—Doxorubicin—urinary bladder cancer	0.000608	0.000831	CcSEcCtD
Cromoglicic acid—Paraesthesia—Methotrexate—urinary bladder cancer	0.000607	0.000829	CcSEcCtD
Cromoglicic acid—Discomfort—Doxorubicin—urinary bladder cancer	0.000603	0.000824	CcSEcCtD
Cromoglicic acid—Dyspnoea—Methotrexate—urinary bladder cancer	0.000602	0.000823	CcSEcCtD
Cromoglicic acid—Somnolence—Methotrexate—urinary bladder cancer	0.000601	0.000821	CcSEcCtD
Cromoglicic acid—Dyspepsia—Methotrexate—urinary bladder cancer	0.000595	0.000813	CcSEcCtD
Cromoglicic acid—Hypotension—Epirubicin—urinary bladder cancer	0.000591	0.000807	CcSEcCtD
Cromoglicic acid—Oedema—Doxorubicin—urinary bladder cancer	0.000585	0.000799	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000585	0.000799	CcSEcCtD
Cromoglicic acid—Fatigue—Methotrexate—urinary bladder cancer	0.000583	0.000796	CcSEcCtD
Cromoglicic acid—Pain—Methotrexate—urinary bladder cancer	0.000578	0.00079	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000576	0.000787	CcSEcCtD
Cromoglicic acid—Insomnia—Epirubicin—urinary bladder cancer	0.000572	0.000781	CcSEcCtD
Cromoglicic acid—Tachycardia—Doxorubicin—urinary bladder cancer	0.000571	0.00078	CcSEcCtD
Cromoglicic acid—Paraesthesia—Epirubicin—urinary bladder cancer	0.000568	0.000776	CcSEcCtD
Cromoglicic acid—Dyspnoea—Epirubicin—urinary bladder cancer	0.000564	0.00077	CcSEcCtD
Cromoglicic acid—Somnolence—Epirubicin—urinary bladder cancer	0.000562	0.000768	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000557	0.000761	CcSEcCtD
Cromoglicic acid—Dyspepsia—Epirubicin—urinary bladder cancer	0.000557	0.000761	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000553	0.000755	CcSEcCtD
Cromoglicic acid—Hypotension—Doxorubicin—urinary bladder cancer	0.000547	0.000747	CcSEcCtD
Cromoglicic acid—Fatigue—Epirubicin—urinary bladder cancer	0.000545	0.000745	CcSEcCtD
Cromoglicic acid—Pain—Epirubicin—urinary bladder cancer	0.000541	0.000739	CcSEcCtD
Cromoglicic acid—Constipation—Epirubicin—urinary bladder cancer	0.000541	0.000739	CcSEcCtD
Cromoglicic acid—Urticaria—Methotrexate—urinary bladder cancer	0.000537	0.000733	CcSEcCtD
Cromoglicic acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.000534	0.00073	CcSEcCtD
Cromoglicic acid—Body temperature increased—Methotrexate—urinary bladder cancer	0.000534	0.00073	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000533	0.000728	CcSEcCtD
Cromoglicic acid—Insomnia—Doxorubicin—urinary bladder cancer	0.000529	0.000723	CcSEcCtD
Cromoglicic acid—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000525	0.000718	CcSEcCtD
Cromoglicic acid—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000522	0.000713	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000521	0.000712	CcSEcCtD
Cromoglicic acid—Somnolence—Doxorubicin—urinary bladder cancer	0.00052	0.000711	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000517	0.000707	CcSEcCtD
Cromoglicic acid—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000515	0.000704	CcSEcCtD
Cromoglicic acid—Fatigue—Doxorubicin—urinary bladder cancer	0.000504	0.000689	CcSEcCtD
Cromoglicic acid—Urticaria—Epirubicin—urinary bladder cancer	0.000502	0.000686	CcSEcCtD
Cromoglicic acid—Pain—Doxorubicin—urinary bladder cancer	0.0005	0.000684	CcSEcCtD
Cromoglicic acid—Constipation—Doxorubicin—urinary bladder cancer	0.0005	0.000684	CcSEcCtD
Cromoglicic acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.0005	0.000683	CcSEcCtD
Cromoglicic acid—Body temperature increased—Epirubicin—urinary bladder cancer	0.0005	0.000683	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000498	0.00068	CcSEcCtD
Cromoglicic acid—Asthenia—Methotrexate—urinary bladder cancer	0.000485	0.000662	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000482	0.000659	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000478	0.000654	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000466	0.000637	CcSEcCtD
Cromoglicic acid—Urticaria—Doxorubicin—urinary bladder cancer	0.000465	0.000635	CcSEcCtD
Cromoglicic acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000463	0.000632	CcSEcCtD
Cromoglicic acid—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000463	0.000632	CcSEcCtD
Cromoglicic acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.000462	0.000632	CcSEcCtD
Cromoglicic acid—Asthenia—Epirubicin—urinary bladder cancer	0.000454	0.00062	CcSEcCtD
Cromoglicic acid—Dizziness—Methotrexate—urinary bladder cancer	0.000447	0.000611	CcSEcCtD
Cromoglicic acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.000433	0.000591	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000431	0.000589	CcSEcCtD
Cromoglicic acid—Rash—Methotrexate—urinary bladder cancer	0.000426	0.000582	CcSEcCtD
Cromoglicic acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000426	0.000582	CcSEcCtD
Cromoglicic acid—Headache—Methotrexate—urinary bladder cancer	0.000423	0.000578	CcSEcCtD
Cromoglicic acid—Asthenia—Doxorubicin—urinary bladder cancer	0.00042	0.000574	CcSEcCtD
Cromoglicic acid—Dizziness—Epirubicin—urinary bladder cancer	0.000418	0.000571	CcSEcCtD
Cromoglicic acid—Nausea—Methotrexate—urinary bladder cancer	0.000401	0.000548	CcSEcCtD
Cromoglicic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	0.0004	0.000547	CcSEcCtD
Cromoglicic acid—Rash—Epirubicin—urinary bladder cancer	0.000399	0.000545	CcSEcCtD
Cromoglicic acid—Dermatitis—Epirubicin—urinary bladder cancer	0.000398	0.000544	CcSEcCtD
Cromoglicic acid—Headache—Epirubicin—urinary bladder cancer	0.000396	0.000541	CcSEcCtD
Cromoglicic acid—Dizziness—Doxorubicin—urinary bladder cancer	0.000387	0.000529	CcSEcCtD
Cromoglicic acid—Nausea—Epirubicin—urinary bladder cancer	0.000376	0.000513	CcSEcCtD
Cromoglicic acid—Rash—Doxorubicin—urinary bladder cancer	0.000369	0.000504	CcSEcCtD
Cromoglicic acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.000369	0.000504	CcSEcCtD
Cromoglicic acid—Headache—Doxorubicin—urinary bladder cancer	0.000367	0.000501	CcSEcCtD
Cromoglicic acid—Nausea—Doxorubicin—urinary bladder cancer	0.000348	0.000475	CcSEcCtD
